Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis - PubMed (original) (raw)
Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis
D S Millar et al. Hum Genet. 1994 Nov.
Abstract
The polymerase chain reaction and direct sequencing were used to determine the nature of the mutations in the antithrombin III (AT3) gene in seven unrelated patients with familial antithrombin III (ATIII) deficiency and recurrent venous thrombosis. Three novel mutations were found, two associated with a type I deficiency state (Pro80-->Thr and His120-->Tyr) manifesting reduced synthesis of ATIII. The other novel lesion (Met251-->Ile) was associated with a dysfunctional ATIII protein (type II ATIII deficiency) and is predicted to interfere either with a heparin-induced conformational change in the ATIII molecule or with docking to thrombin. A novel polymorphism (Tyr158-->Cys) was also found to occur in several individuals of Scandinavian origin.
Similar articles
- De novo splice site mutation in the antithrombin III (AT3) gene causing recurrent venous thrombosis: demonstration of exon skipping by ectopic transcript analysis.
Berg LP, Grundy CB, Thomas F, Millar DS, Green PJ, Slomski R, Reiss J, Kakkar VV, Cooper DN. Berg LP, et al. Genomics. 1992 Aug;13(4):1359-61. doi: 10.1016/0888-7543(92)90070-9. Genomics. 1992. PMID: 1505975 - Nonsense mutation Arg197stop in a Dutch family with type 1 hereditary antithrombin (AT) deficiency causing thrombophilia.
Michiels JJ, van der Luit L, van Vliet HH, Jochmans K, Lissens W. Michiels JJ, et al. Thromb Res. 1995 May 1;78(3):251-4. doi: 10.1016/0049-3848(95)90875-g. Thromb Res. 1995. PMID: 7631305 No abstract available. - A frameshift mutation leading to type 1 antithrombin deficiency and thrombosis.
Olds RJ, Lane DA, Finazzi G, Barbui T, Thein SL. Olds RJ, et al. Blood. 1990 Dec 1;76(11):2182-6. Blood. 1990. PMID: 1979501 - The molecular genetics of familial venous thrombosis.
Cooper DN. Cooper DN. Baillieres Clin Haematol. 1994 Sep;7(3):637-74. doi: 10.1016/s0950-3536(05)80102-7. Baillieres Clin Haematol. 1994. PMID: 7841604 Review. - Molecular genetics of inherited antithrombin III deficiencies.
Prochownik EV. Prochownik EV. Am J Med. 1989 Sep 11;87(3B):15S-18S. doi: 10.1016/0002-9343(89)80525-x. Am J Med. 1989. PMID: 2572168 Review.
Cited by
- Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema.
Verpy E, Biasotto M, Brai M, Misiano G, Meo T, Tosi M. Verpy E, et al. Am J Hum Genet. 1996 Aug;59(2):308-19. Am J Hum Genet. 1996. PMID: 8755917 Free PMC article. - C1 inhibitor: molecular and clinical aspects.
Cicardi M, Zingale L, Zanichelli A, Pappalardo E, Cicardi B. Cicardi M, et al. Springer Semin Immunopathol. 2005 Nov;27(3):286-98. doi: 10.1007/s00281-005-0001-4. Epub 2005 Nov 11. Springer Semin Immunopathol. 2005. PMID: 16267649 Review. - Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.
Izaguirre G, Aguila S, Qi L, Swanson R, Roth R, Rezaie AR, Gettins PG, Olson ST. Izaguirre G, et al. J Biol Chem. 2014 Dec 5;289(49):34049-64. doi: 10.1074/jbc.M114.611707. Epub 2014 Oct 20. J Biol Chem. 2014. PMID: 25331949 Free PMC article. - Molecular evolution of plasminogen activator inhibitor-1 functional stability.
Berkenpas MB, Lawrence DA, Ginsburg D. Berkenpas MB, et al. EMBO J. 1995 Jul 3;14(13):2969-77. doi: 10.1002/j.1460-2075.1995.tb07299.x. EMBO J. 1995. PMID: 7621813 Free PMC article.
References
- Thromb Haemost. 1993 Aug 2;70(2):361-9 - PubMed
- Nucleic Acids Res. 1990 Sep 25;18(18):5583 - PubMed
- J Biol Chem. 1989 Feb 25;264(6):3111-5 - PubMed
- Thromb Res. 1993 Jan 1;69(1):1-58 - PubMed
- Blood. 1991 Aug 15;78(4):1027-32 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Miscellaneous